Immediate Impact

56 standout
Sub-graph 1 of 24

Citing Papers

Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements
2024 Standout
Drug resistance in ovarian cancer: from mechanism to clinical trial
2024 Standout
3 intermediate papers

Works of Amy E. Bland being referenced

Elevated MAL expression is accompanied by promoter hypomethylation and platinum resistance in epithelial ovarian cancer
2009
Cyclin E Overexpression in Epithelial Ovarian Cancer Characterizes an Etiologic Subgroup
2008

Author Peers

Author Last Decade Papers Cites
Amy E. Bland 183 225 56 64 15 355
Augusto F. Mesia 154 164 54 74 16 322
Masashi Nishiya 199 222 76 96 18 382
Kevin L. Hall 124 162 77 62 16 320
Fuminori Ito 205 212 35 58 23 349
Atsuya Fujito 195 117 27 96 12 384
E. Cagnur Ulukus 258 235 23 55 12 352
Seung‐Chul Yoo 256 208 81 38 20 408
Chloe E. Barr 157 182 44 79 20 379
H.W.H.M. van der Putten 162 222 61 98 16 397
J.T. Chambers 221 203 60 41 23 353

All Works

Loading papers...

Rankless by CCL
2026